May 18, 2024  
2022-2023 Catalog 
    
2022-2023 Catalog [ARCHIVED CATALOG]

RESP 106 - Cardiopulmonary Pharmacology


PREREQUISITES: Program Chair Approval
PROGRAM: Respiratory Therapy
CREDIT HOURS MIN: 3
LECTURE HOURS MIN: 3
DATE OF LAST REVISION: Fall, 2019

The most common pharmacological agents currently being administered are discussed according to all body systems and in relations to the nervous system and its receptors. Emphasis is placed on classifications, indications, side effects, dosages, and routes of administration. Medication discussion to include, but not limited to respiratory, cardiovascular, emergency drugs, anti-infective, diuretics and sedation agents.

MAJOR COURSE LEARNING OBJECTIVES: FROM 2020 NBRC MATRIX: Upon successful completion of this course the student will be expected to:

  1. Evaluate data in the patient record (e.g., patient history of present illness (HPI), orders, medication reconciliation, progress notes, DNR status/advanced directives, social/family/medical hx, and patient’s pathophysiological state)
  2. Evaluate lab data (CBC, electrolytes, coagulation, C&S, sputum, cardiac biomarkers
  3. Perform clinical assessment by interviewing patient to assess:
    1. Level of consciousness and orientation, emotional state, and ability to cooperate
    2. Shortness of breath, sputum production, and exercise tolerance such as exercise induced asthma)
    3. Activities of daily living
  4. Perform clinical assessment by inspection to assess cough, sputum amount and character
  5. Perform clinical assessment to assess breath sounds
  6. Discuss administration of SVN, MDI/slow mist inhalers, DPI, and valved holding chambers:
    1. Infection control
    2. Assembling/troubleshooting of equipment
    3. Determine which modality is most appropriate for age specific
    4. Determine which modality is most appropriate for clinical presentation
  7. Ensure modifications of respiratory care plan for:
    1. Adverse or life threatening events
    2. Starting treatment based on patient response
    3. Discontinuing treatment based on patient response
  8. Ensure modifications of respiratory care plan by recommending and implementing treatments based on patient response and national guidelines (ARDS Net, NAEPP, and GOLD) for selective diseases
  9. Administer medications and specialty gases to ensure modifications are made to the respiratory care plan to include indications, contraindications, hazards, mode of action, classes/subclasses, concentration, doses, names (generic/brand) and frequencies:
    1. Bronchodilators (Albuterol, Levalbuterol, Salmeterol, Formoterol, Arformoterol, Ipratropium bromide, Tiotropium bromide, Methylxanthines)
    2. Corticosteroids (Fluticasone, Beclomethasone, Budesonide, Flunisolide, Triamcinolone, Prednisone, Methylprednisolone)
    3. Combining Medications (Combivent, Duoneb, Advair, Symbicort)
    4. Mucolytics (Acetylcysteine, Sodium Bicarbonate, Recombinant Human DNAse)
    5. Pulmonary Vasodilators (Prostacyclins: epoprostenol, IIoprost, Sildenafil, INO)
    6. Wetting Agents Saline solutions (0.45%, 0.9%, 1.8-15%)
    7. Leukotriene Modifiers (Montelukast, Zafirlukast, Zileuton)
    8. Mast Cell Stabilizers (Cromolyn sodium)
    9. Mucosal Vasoconstrictors/Decongestants (aerosolized racemic epinephrine)
    10. Inotropic Agents (Digitalis, Digoxin)
    11. Anti-arrhythmic Agents (Amiodarone, Procainamide, Verapamil, Lidocaine, Atropine, Epinephrine)
    12. Antianginal Agents (Nitroglycerin)
    13. Vasodilator Drugs (Nitroprusside, Milrinone)
    14. Vasoconstrictor/Vasopressor Drugs (Epinephrine, Norepinephrine, Dopamine, Dobutamine)
    15. Diuretics (Furosemide, Mannitol, Acetazolamide)
    16. Neuromuscular Blocking Agents (Succinylcholine, Neostigmine, Pancuronium, Vecuronium, Atracurium, Cisatracurium, Rocuronium)
    17. Sedatives (Alprazolam, Diazepam, Midazolam, Lorazepam)
    18. Anesthetics (Propofol, Ketamine)
    19. Analgesics (Morphine, Codeine, Meperidine, Fentanyl, Hydromorphone, Oxycodone, Hydrocodone)
    20. Surfactant Replacement Therapy (Calfactant, Beractant, Poractant alfa, Lucinactant)
    21. Antimicrobial agents (Ampicillin, Amoxicillin, Nafcillin, Cephalexin, Cefazolin, Cefaclor, Cefoxitin, Ceftriaxone, Cefepime, Amikacin, Gentamicin, Tobramycin, Vancomycin, Erythromycin, Azithromycin, Isoniazid, Rifampin, Ethambutol, Streptomycin, Cycloserine, Ethionamide)
    22. Antiviral Agent (Ribavirin)
    23. Anti-pneumocystis Agent (Pentamidine)
    24. Vaccines (Respiratory Syncytial Virus Immune Globulin Intravenous, Palivizumab)


COURSE CONTENT: Topical areas of study include -  

  • Pharmacokinetics / Pharmacodynamics
  • Dosage calculations
  • Peripheral nervous system agents (Cholinergic, Nicotinic, Muscarinic)
  • Respiratory treatments (Antihistamine, Adrenergic, Xanthines, Stimulants)
  • Glucocorticoids
  • Mucolytic agents
  • Antibacterial medications
  • Antiviral and antifungal agents
  • Cardiovascular agents (Cardiotonics, Antianginals, Antiarrhythmics, Antihypertensive)
  • Diuretics
  • Psycho hypnotic
  • Analgesic
  • Anesthetics
  • Evaluations

 
Course Addendum - Syllabus (Click to expand)